A - Agilent Technologies - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00846U1016

Chromatography Systems, Spectrometry Instruments, Laboratory Software, Automation Systems

Agilent Technologies, Inc. is a leading provider of application-focused solutions for the life sciences, diagnostics, and applied chemical markets globally.

The company operates through three main segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment is a powerhouse, offering a wide range of innovative products and solutions, including liquid chromatography systems, mass spectrometry systems, gas chromatography systems, inductively coupled plasma mass spectrometry instruments, and atomic absorption instruments, among others. These solutions cater to various industries, including pharmaceuticals, biotechnology, and academia, enabling researchers and scientists to analyze and understand complex biological systems.

The Diagnostics and Genomics segment is focused on genomics, nucleic acid contract manufacturing, research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis. This segment is critical in enabling the development of new diagnostic tools and therapies, ultimately improving human health and quality of life.

The Agilent CrossLab segment provides a comprehensive portfolio of products and services, including GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. Additionally, this segment offers a range of services, including repairs, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services, ensuring that customers have access to the support they need to optimize their laboratory operations.

Agilent Technologies, Inc. markets its products and services through a diverse range of channels, including direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. This multi-channel approach enables the company to reach a broad customer base, providing solutions to researchers, scientists, and healthcare professionals worldwide.

Headquartered in Santa Clara, California, Agilent Technologies, Inc. was incorporated in 1999 and has since established itself as a leader in the life sciences, diagnostics, and applied chemical markets. With a strong commitment to innovation and customer satisfaction, the company continues to drive progress in these fields, ultimately improving human life and well-being.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for A - Agilent Technologies  - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for A - Agilent Technologies  - Stock & Dividends

A Stock Overview

Market Cap in USD 36,870m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 1999-11-18

A Stock Ratings

Growth 5y 47.9
Fundamental 67.1
Dividend 38.2
Rel. Performance vs Sector -0.55
Analysts 3.47/5
Fair Price Momentum 126.21 USD
Fair Price DCF 138.97 USD

A Dividends

Dividend Yield 12m 0.71%
Yield on Cost 5y 1.40%
Dividends CAGR 5y 6.27%
Payout Consistency 63.1%

A Growth Ratios

Growth 12m 4.00%
Growth Correlation 12m 44%
Growth Correlation 3m -38%
CAGR 5y 14.55%
CAGR/Mean DD 5y 0.95
Sharpe Ratio 12m -0.05
Alpha vs SP500 12m -18.01
Beta vs SP500 5y weekly 0.94
ValueRay RSI 51.75
Volatility GJR Garch 1y 25.69%
Price / SMA 50 -3.61%
Price / SMA 200 0.3%
Current Volume 1731.4k
Average Volume 20d 2344.9k

External Links for A Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of A stocks?
As of July 21, 2024, the stock is trading at USD 131.78 with a total of 1,731,400 shares traded.
Over the past week, the price has changed by -0.34%, over one month by -0.53%, over three months by -0.53% and over the past year by +3.92%.
What are the forecast for A stock price target?
According to ValueRays Forecast Model, A Agilent Technologies will be worth about 139.6 in July 2025. The stock is currently trading at 131.78. This means that the stock has a potential upside of +5.96%.
Issuer Forecast Upside
Wallstreet Target Price 138.1 4.80
Analysts Target Price 135.8 3.01
ValueRay Target Price 139.6 5.96

Exploring Agilent Technologies: A Comprehensive Overview

History of Agilent Technologies

Agilent Technologies, Inc., often simply called Agilent, has a rich history that dates back to its inception in 1999. It was born as a spin-off from Hewlett-Packard (HP), carrying forward the legacy of innovation in electronics and serving as HP’s test- and measurement-equipment division before becoming an independent entity. This separation allowed Agilent to focus more intently on its core markets, including chemical analysis, life sciences, diagnostics, and electronics.

Core and Side Businesses

At its core, Agilent is dedicated to the development and manufacturing of analytical instruments, software, services, and consumables for the entire laboratory workflow. The company operates mainly within three segments:

  • Life Sciences and Applied Markets (LSAG): Provides instruments and software that serve a wide range of applications, including pharmaceutical, environmental, and food testing.
  • Diagnostics and Genomics (DGG): Offers solutions in diagnostic testing and genomics with a focus on precision medicine.
  • Agilent CrossLab (ACG): Delivers comprehensive services and consumables for laboratory efficiency and optimization.

Besides its core activities, Agilent has expanded into related businesses that complement its main operations. These include acquisitions and partnerships aimed at enhancing its product lines and expanding its technology offerings, thus maintaining a competitive edge in the market.

Current Market Status

As of now, Agilent Technologies, Inc. remains a global leader in the life sciences, diagnostics, and applied chemical markets. The company has demonstrated resilience and growth, benefiting from a strong product pipeline, strategic acquisitions, and a focus on customer-centric solutions. Agilent’s commitment to innovation has also enabled it to navigate challenges and capitalize on emerging scientific and technological trends. With its solid financial performance and strategic initiatives aimed at expanding global reach and enhancing operational efficiencies, Agilent continues to be well-positioned for future growth.